XML 59 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Deficit (Details Textual) - USD ($)
1 Months Ended 2 Months Ended 9 Months Ended 12 Months Ended
Oct. 20, 2016
Aug. 03, 2018
Jul. 20, 2017
Nov. 30, 2018
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Stockholders' Deficit (Textual)              
Common stock authorized         100,000,000   100,000,000
Common stock, par value         $ 0.001   $ 0.001
Common stock, shares issued         9,656,505   7,864,994
Common stock, shares outstanding         9,656,505   7,864,994
Preferred stock, par value         $ 0.001   $ 0.001
Preferred stock, shares authorized         10,000,000   10,000,000
Purchase agreement, description       The Company issued and sold an aggregate of 170,000 additional Units to the Purchasers, for total gross proceeds to the Company of approximately $425,000 before deducting offering expenses.      
Aggregrate sale of shares         445,200    
Deducting offering expenses.         $ 1,113,000    
Maximum offering, units   4,600,000          
Risk free interest rate         2.80% 1.90%  
Expected stock price volatility         49.80% 47.80%  
Expected life of options (years)         5 years 5 years  
Expected dividend yield         0.00% 0.00%  
Liability         $ 4,614,611   $ 5,286,596
Legal costs         833,470   $ 553,037
Acquired percentage     100.00%        
Aggregate shares issued of the then-outstanding NeuroOne shares     3,500,000        
2018 Private Placement [Member]              
Stockholders' Deficit (Textual)              
Purchase agreement, description   (i) 1 share (each, a "Share") of the Company's common stock and (ii) a warrant to purchase 1 share of common stock at an initial exercise price of $3.00 per share (the "2018 Warrants").          
Maximum offering, units   4,000,000          
Offering price, per share   $ 2.50          
Cost of issuance         173,067    
Cash commission, percentage   10.00%          
Exercise price, per share   $ 3.45          
Common stock purchase price, per share   10.00%          
Warrants exercisable, term   5 years          
Liability         26,878    
Legal costs         $ 62,389    
Over-Allotment Option [Member]              
Stockholders' Deficit (Textual)              
Maximum offering, units   600,000          
Common Stock [Member]              
Stockholders' Deficit (Textual)              
Maximum offering, units   4,000,000          
Net exchanges of shares             859,976
Warrant [Member]              
Stockholders' Deficit (Textual)              
Warrants exercisable, term   5 years          
NeuroOne, Inc. [Member]              
Stockholders' Deficit (Textual)              
Common stock, shares issued 5,131,514            
Exercise price, per share $ 0.03            
Acquired percentage     100.00%        
Aggregate shares issued of the then-outstanding NeuroOne shares     6,291,994        
Net exchanges of shares     1,573,000        
Subscription receivable $ 9,050